Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2025/09/094430
CTRI/2025/09/094430Not yet recruitingPhase 2

An Exploratory Study To Compare The Effect Of Madhudaka And Triyushnadi Mantha In The Management Of Atisthoulya (Obesity)

PREETI CHAUHAN1 site in 1 country60 target enrollmentStarted: December 18, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
REDUCTION IN SIGN AND SYMPTOMS OF ATISTHOULYA BY DECREASING BMI BREATHLESSNESS SNORING
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

AN EXPLORATRY STUDY WILL BE DONE ON TWO GROUPS EACH CONSISTING 30 PATIENTS. ONE GROUP WILL BE ADMINISTERED MADHUDAKA IN QUANTITY OF 2 PAL OR 96GMS O.D. AND OTHER GROUP WILL BE ADMINISTERED TRIYUSHNADI MANTHA IN QUANTITY OF 2 PAL OR 96GMS O.D. FOR 45 DAYS. THEN PATIENTS WILL BE ASSESS BEFORE AND AFTER THE TRIAL ON THE BASIS OF SUBJECTIVE AND OBJECTIVE CRITERIA OF ATISTHOULYA AND FOLLOW UP WILL BE DONE EVERY 15TH DAY. THE DATA WILL BE COLLECTED AND ANALYZED STATISTICALLY USING APPROPRIATE TESTS.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •The Patient Age Between 16-65 Years Irrespective Of Their Caste, Race And Sex Etc.
  • •BMI Greater Than 25 And Above.
  • •The Patient Having Clinical Signs & Symptoms Of Obesity.
  • •The Patient Should Not Be On Any Other Medicine For Atisthoulya.

Exclusion Criteria

  • •Patient With Endocrinal Disorder (D.M.) And Other Systemic Disease.
  • •Patient With Long Term Steroid Treatment.
  • •The Patient Having Obesity With Secondary In Origin.
  • •Pregnant Women Drug Induced Obesity.
  • •Patient Who Has BMI Less Then 25.

Outcomes

Primary Outcomes

REDUCTION IN SIGN AND SYMPTOMS OF ATISTHOULYA BY DECREASING BMI BREATHLESSNESS SNORING

Time Frame: SIX WEEKS

Secondary Outcomes

  • IMPROVEMENT IN SUBJECTIVE AND OBJECTIVE ASSESSMENT CRITERIA OF ATISTHOULYA SUCH AS LESSER BMI(45 DAYS)

Investigators

Sponsor
PREETI CHAUHAN
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

DR SAURABH AGARWAL

PGIA JODHPUR

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 2
A study to compare the effect of two ayurvedic medicines and ayurvedic lepa in the management of melasama.
CTRI/2025/07/091770pt khushilal sharma govt autonomous ayurveda college and institue bhopal mp40
Not yet recruiting
Phase 2/3
Effect of Shigru Taila Nasya and Anu Taila Nasya in management of Vataja Pratishaya (Allergic Rhinitis)
CTRI/2024/12/078578Smt K C Ajmera Ayurved Mahavidyalya DeopurDhule70
Not yet recruiting
Phase 3
MANAGEMENT OF GRIDHRASI THROUGH SHEPHALIKA PATRA KASHAYAM AND RASNA GUGGULU
CTRI/2025/11/096832Govt ayurveda college nipaniya rewa mp40
Not yet recruiting
Phase 1/2
A study on the role of Mahasneha and Dashmoola Ksheera Janu Basti in the management of Sandhivata (Osteo-Arthritis)
CTRI/2024/10/075973Pt Khushilal Sharma Government Autonomous Ayurveda College and Institute Science Hills Bhopal MP40
Not yet recruiting
Phase 2/3
Application Of Medicated Powder On Mouth Ulcer In Children
CTRI/2025/07/090749Dr M Shriraksha Bangera40